X
07Jan

DEAL WATCH: End-of-Year Biosimilar Agreements

Goodwin | | Return|
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/deal-watch-end-of-year-biosimilar-10061/

Related

When a Final Release is not “Final”

In a recent opinion issued by the United States Court of Federal Claims, Meridian Engineering Compan...

Read More >

California Prohibits Mandatory Employment Arbitration

California Governor Gavin Newsom just signed AB 51 into law, which means that effective January 1, 2...

Read More >

Environmental and Regulatory Highlights of the Fall 2019 Unified Agenda of Regulatory Actions

In late December, the Office of Management and Budget (OMB) released the “Fall 2019 Unified Agenda ...

Read More >

4-Point Plan To Avoid Costly Workplace Mistakes

When a California Court of Appeal revived a workplace lawsuit alleging state law disability discrimi...

Read More >

New and updated standard form contracts (UK construction focus)

Our latest round-up of new and amended standard form construction contracts....By: Dentons

Read More >

Engage in settlement talks or pay the price

Belief in a strong case is not a good enough reason to refuse settlement overtures. So held the cour...

Read More >